• 

  March 6, 2025

  Trestle Bio Announces Research Collaboration with Humacyte

  R.D. Solorzano

• 

  February 26, 2025

  Xenotransplantation Advances: United Therapuetics and eGensis Companies to Watch

  R.D. Solorzano

• 

  February 18, 2025

  ARMI BioFabUSA A Catalyst for Regenerative Medicine

  R.D. Solorzano

• 

  February 18, 2025

  Tissue Therapeutics: The Curative Potential of Combining Cells & Biomaterials

  R.D. Solorzano

• 

  February 6, 2025

  EU-Funded micro2MACRO Project Aims to Push Cartilage Tissue Regeneration with Bioprinting

  R.D. Solorzano

• 

  February 6, 2025

  Auxilium Biotechnologies Achieves Bioprinting Milestone Aboard the ISS

  R.D. Solorzano

• 

  February 5, 2025

  United Therapeutics Breaks New Ground with FDA-Cleared Xenotransplantation Trial

  R.D. Solorzano

• 

  February 4, 2025

  Handheld Bioprinting with Kombucha-Based Bioink

  R.D. Solorzano

• 

  February 1, 2025

  Time Code: Improved Printing Code for 3D Bioprinting

  R.D. Solorzano

• 

  February 1, 2025

  MEDELLAPRO®: Endotoxin-Controlled Bioprinting Materials

  R.D. Solorzano